» Articles » PMID: 25437608

The Natural Antimicrobial Enzyme Lysozyme is Up-Regulated in Gastrointestinal Inflammatory Conditions

Overview
Journal Pathogens
Date 2014 Dec 2
PMID 25437608
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The cells that line the mucosa of the human gastrointestinal tract (GI, that is, oral cavity, oesophagus, stomach, small intestine, large intestine, and rectum) are constantly challenged by adverse micro-environmental factors, such as different pH, enzymes, and bacterial flora. With exception of the oral cavity, these microenvironments also contain remnant cocktails of secreted enzymes and bacteria from upper organs along the tract. The density of the GI bacteria varies, from 103/mL near the gastric outlet, to 1010/mL at the ileocecal valve, to 1011 to 1012/mL in the colon. The total microbial population (ca. 1014) exceeds the total number of cells in the tract. It is, therefore, remarkable that despite the prima facie inauspicious mixture of harmful secretions and bacteria, the normal GI mucosa retains a healthy state of cell renewal. To counteract the hostile microenvironment, the GI epithelia react by speeding cell exfoliation (the GI mucosa has a turnover time of two to three days), by increasing peristalsis, by eliminating bacteria through secretion of plasma cell-immunoglobulins and by increasing production of natural antibacterial compounds, such as defensin-5 and lysozyme. Only recently, lysozyme was found up-regulated in Barrett's oesophagitis, chronic gastritis, gluten-induced atrophic duodenitis (coeliac disease), collagenous colitis, lymphocytic colitis, and Crohn's colitis. This up-regulation is a response directed to the special types of bacteria recently detected in these diseases. The aim of lysozyme up-regulation is to protect individual mucosal segments to chronic inflammation. The molecular mechanisms connected to the crosstalk between the intraluminal bacterial flora and the production of lysozyme released by the GI mucosae, are discussed. Bacterial resistance continues to exhaust our supply of commercial antibiotics. The potential use of lysozyme to treat infectious diseases is receiving much attention.

Citing Articles

Preliminary exploration of mRNA, lncRNA, and miRNA expressions in the bovine jejunum unveils novel aspects of Mycobacterium avium subspecies paratuberculosis infections.

Gao Y, Cao J, Han B, Sun D BMC Genomics. 2025; 26(1):108.

PMID: 39905315 PMC: 11796175. DOI: 10.1186/s12864-025-11299-1.


Vasoactive intestinal peptide promotes secretory differentiation and mitigates radiation-induced intestinal injury.

Agibalova T, Hempel A, Maurer H, Ragab M, Ermolova A, Wieland J Stem Cell Res Ther. 2024; 15(1):348.

PMID: 39380035 PMC: 11462795. DOI: 10.1186/s13287-024-03958-z.


Nanoparticle-Based Drug Delivery Systems for Inflammatory Bowel Disease Treatment.

Gao J, Li J, Luo Z, Wang H, Ma Z Drug Des Devel Ther. 2024; 18:2921-2949.

PMID: 39055164 PMC: 11269238. DOI: 10.2147/DDDT.S461977.


Healthy Effects of Milk and Dairy Product Consumption in the Mediterranean Area and Japan.

Jirillo F Endocr Metab Immune Disord Drug Targets. 2024; 24(15):1813-1822.

PMID: 38994611 DOI: 10.2174/0118715303289711240703080701.


Exploring the Interplay between Nutrients, Bacteriophages, and Bacterial Lipases in Host- and Bacteria-mediated Pathogenesis.

Ghadimi D, Folster-Holst R, Ebsen M, Rocken C, Dorfer C, Uchiyama J Endocr Metab Immune Disord Drug Targets. 2023; 24(8):930-945.

PMID: 37957846 DOI: 10.2174/0118715303257321231024094904.


References
1.
Monstein H, Tiveljung A, Kraft C, Borch K, Jonasson J . Profiling of bacterial flora in gastric biopsies from patients with Helicobacter pylori-associated gastritis and histologically normal control individuals by temperature gradient gel electrophoresis and 16S rDNA sequence analysis. J Med Microbiol. 2000; 49(9):817-822. DOI: 10.1099/0022-1317-49-9-817. View

2.
Rubio C, Hubbard G . Chronic colitis in baboons: similarities with chronic colitis in humans. In Vivo. 2001; 15(1):109-16. View

3.
Campbell D, Warren B, Thomas J, Figura N, Telford J, Sullivan P . The African enigma: low prevalence of gastric atrophy, high prevalence of chronic inflammation in West African adults and children. Helicobacter. 2002; 6(4):263-7. DOI: 10.1046/j.1083-4389.2001.00047.x. View

4.
Torbenson M, Abraham S, Boitnott J, Yardley J, Wu T . Autoimmune gastritis: distinct histological and immunohistochemical findings before complete loss of oxyntic glands. Mod Pathol. 2002; 15(2):102-9. DOI: 10.1038/modpathol.3880499. View

5.
Petersson F, Borch K, Franzen L . Prevalence of subtypes of intestinal metaplasia in the general population and in patients with autoimmune chronic atrophic gastritis. Scand J Gastroenterol. 2002; 37(3):262-6. DOI: 10.1080/003655202317284156. View